The bottle features a dropper with a one-way valve to ensure that no contaminated liquid can be reintroduced after a drop has been dispensed, removing the need for preservatives and preventing bacterial contamination over the 28-day in-use shelf-life.
Further informationView Eydelto drug record
In addition, silver is incorporated within the nozzle top and cap to prevent bacterial contamination of any residual solution which may remain on the tip. As a result Eydelto and Eylamdo should not be used in patients with a history of contact hypersensitivity to silver.
Eydelto contains 20mg/ml dorzolamide and is indicated for use as monotherapy where β-blockers are ineffective or contraindicated, or as an adjunct to β-blockers in adults with ocular hypertension, open-angle or pseudoexfoliative glaucoma.
Eylamdo contains 20mg/ml dorzolamide and 5mg/ml timolol. It indicated for the treatment of raised intraocular pressure in adults with open-angle or pseudoexfoliative glaucoma when β-blocker monotherapy is inadequate.